Downregulation of VRK1 Inhibits Progression of Lung Squamous Cell Carcinoma through DNA Damage

<div>(a) Expression levels of VRK1 in 486 lung cancers and 338 paraneoplastic tissues based on GEPIA-LUSC dataset; (b) Kaplan–Meier survival curves of LUSC patients based on GEPIA-LUSC dataset; and (c) immunohistochemical staining showing VRK1 protein expression in normal and LUSC tissues (200x).</div>

Canadian Respiratory Journal

fig1

Figure 1

Figure 1: Downregulation of VRK1 Inhibits Progression of Lung Squamous Cell Carcinoma through DNA Damage 